NCT00774007View on ClinicalTrials.gov

A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

mesalazine

DRUG

placebo

Trial Locations (1)

40138

Department of Internal Medicine & Gastroenterology, Bologna

All Listed Sponsors
collaborator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

lead

SOFAR S.p.A.

INDUSTRY

NCT00774007 - A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter